Join
Live feed
·
INSIDERFilingvia Quantisnow
Candel Therapeutics Inc. logo

Chief Technology Officer Tyagarajan Seshu was granted 5,353 shares, increasing direct ownership by 6% to 90,865 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CADL (Candel Therapeutics Inc.) and more on Quantisnow.